Dr. Marty Pets Establishes Richfield, Wisconsin, Manufacturing Operations
03/23/2023
Golden Pet Manufacturing will be run under Dr. Marty Pets' affiliate, Golden Hippo. The new facility will enable Dr. Marty Pets to personally monitor the quality of the ingredients and source its own raw ingredients. The new food plan will increase the production to fulfill the high demand of best-selling products.
"This gives us the opportunity to trace raw ingredients, improve upon our already high-quality control and create a better sustainability story for our food products,” Dan Markenson, Head of Retail, Dr. Marty Pets said. "Our retail partners are excited about our ability to continue our great level of service as we rapidly grow our business with them."
Founded by Dr. Marty Goldstein, Dr. Marty Pets was created to help support pet health through cutting-edge, premium freeze-dried raw dog and cat food and supplements. The company’s premium pet formulas are manufactured in the U.S.
Project Announcements
Contec Industrial Automation Solutions Plans Greensboro, North Carolina, Operations
01/21/2025
Canada-Based Cardiff Products Plans West Columbia, South Carolina, Beverage Packaging Operations
01/17/2025
Messer Plans Berryville, Arkansas, Air Separation Operations
01/16/2025
NewGlobal Ventures Plans Estancia Valley, New Mexico, Canning Operations
01/16/2025
Oxeon Energy Expands Davis County, Utah, Production Operations
01/13/2025
Nucor Towers & Structures Plans Brigham City, Utah, Production Operations
01/13/2025
Most Read
-
2024's Leading Metro Locations: U.S. Cities on the Rise Amid an Economic Reshuffling
Q4 2024
-
The Workforce Factor: How States Are Competing to Build Tomorrow's Talent
Q4 2024
-
Best Practices in Incentives Procurement
Q4 2024
-
Five Strategies to Tackle the Data Center Talent Shortage
Q4 2024
-
Microsoft-Three Mile Island Deal Could Signal Path for Nuclear Power to Strengthen Partnerships with Big Tech
Q4 2024
-
Why Decarbonization Goals Start with Site Selection
Q4 2024
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024